Based on the provided data, the forecasted values for respiratory system medicine sales in Canada (expressed in US Dollars per capita) are:
- 2024: $52.6
- 2025: $52.9 (+0.57%)
- 2026: $53.2 (+0.57%)
- 2027: $53.5 (+0.56%)
- 2028: $53.8 (+0.56%)
The compound annual growth rate (CAGR) over this forecasted period is approximately 0.56%.
Future Trends to Watch
The market for respiratory system medicine in Canada shows a steady but modest growth trend in the forecasted period. Factors to watch include advancements in medical technology, demographic shifts (like an aging population), and the impact of healthcare policies. Additionally, trends in respiratory diseases, potential new drug approvals, and economic conditions could influence these forecasts.
